 |
|
|
Scott Foster is an associate and member of Gowlings’ Intellectual Property Group. Scott's practice focuses primarily on contentious IP in the fields of trade-marks, copyright, trade-secrets and breach of confidence, and patents; particularly cases involving technical subject matter in pharmaceuticals, electronics, medical devices, biotechnology and chemistry.
Scott qualified as an English solicitor in 2004 and worked in the Intellectual Property department of Baker & Mckenzie in London until 2006. At Baker & Mckenzie, Scott's practice encompassed a range of both contentious and non-contentious aspects of IP law including trade marks, patents, copyright and the internet. Scott has experience of IP enforcement and brand protection work, and was involved in enforcement programs in the UK and throughout Europe for a wide range of clients in varied industries including pharmaceuticals, electronics and luxury goods.
In 2006, Scott moved to Bristows in London to focus on patent litigation. Scott has experience of patent litigation before the English High Court and Court of Appeal in a range of industry sectors; including pharmaceuticals, biotechnology and medical devices. 
- "Ruling by European Court of Justice on Supplementary Protection Certificates", Eurowatch, Volume 17, Number 12 (2005)
- "The extending reach of competition law in the pharma sector - AstraZeneca gets a stomach ulcer", Pharmaceutical Law Insight pp 14 - 16, March 2006.
- "Patent Litigation: Guidance from the UK Patents Court on Streamlined Procedure, Expert Evidence and Patentability", BNAI's IP & Technology Report, March 2006.
- “Product Liability – how to minimise risk” BioPartnering Today, Spring 2006
- "Ambush Marketing and the London 2012 Olympics", BNAI's IP Brands Update, October 2006.
- “The new “radically” different approach to patent amendment” Patent World, March 2008
- “New medical inventions guidelines published” Managing Intellectual Property, November 2008
|
|
|
|
|
|
|